 Lung Diseases, Interstitial
"Lung Diseases, Interstitial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Descriptor ID |
D017563
|
| MeSH Number(s) |
C08.381.483
|
| Concept/Terms |
Lung Diseases, Interstitial- Lung Diseases, Interstitial
- Interstitial Lung Disease
- Lung Disease, Interstitial
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases
Pneumonia, Interstitial- Pneumonia, Interstitial
- Interstitial Pneumonia
- Interstitial Pneumonias
- Pneumonias, Interstitial
- Pneumonitis, Interstitial
- Interstitial Pneumonitides
- Interstitial Pneumonitis
- Pneumonitides, Interstitial
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Interstitial".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Interstitial".
This graph shows the total number of publications written about "Lung Diseases, Interstitial" by people in this website by year, and whether "Lung Diseases, Interstitial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1995 | 0 | 1 | 1 | | 1996 | 3 | 0 | 3 | | 1998 | 1 | 3 | 4 | | 1999 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 6 | 0 | 6 | | 2003 | 3 | 2 | 5 | | 2004 | 8 | 2 | 10 | | 2005 | 7 | 1 | 8 | | 2006 | 10 | 3 | 13 | | 2007 | 11 | 1 | 12 | | 2008 | 5 | 0 | 5 | | 2009 | 16 | 1 | 17 | | 2010 | 11 | 1 | 12 | | 2011 | 11 | 1 | 12 | | 2012 | 16 | 3 | 19 | | 2013 | 20 | 0 | 20 | | 2014 | 15 | 1 | 16 | | 2015 | 18 | 2 | 20 | | 2016 | 15 | 4 | 19 | | 2017 | 13 | 0 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Jun S, Kim N, Seo JB, Lee YK, Lynch DA. An Ensemble Method for Classifying Regional Disease Patterns of Diffuse Interstitial Lung Disease Using HRCT Images from Different Vendors. J Digit Imaging. 2017 Dec; 30(6):761-771.
-
Salisbury ML, Lynch DA. Toward Early Identification of Clinically Relevant Interstitial Lung Disease. Am J Respir Crit Care Med. 2017 12 01; 196(11):1368-1369.
-
Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, Behr J, Cottin V, Danoff SK, Flaherty KR, Lederer DJ, Lynch DA, Martinez FJ, Raghu G, Travis WD, Udwadia Z, Wells AU, Collard HR. A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective. Am J Respir Crit Care Med. 2017 Nov 15; 196(10):1249-1254.
-
Schiller HB, Mayr CH, Leuschner G, Strunz M, Staab-Weijnitz C, Preisendörfer S, Eckes B, Moinzadeh P, Krieg T, Schwartz DA, Hatz RA, Behr J, Mann M, Eickelberg O. Deep Proteome Profiling Reveals Common Prevalence of MZB1-Positive Plasma B Cells in Human Lung and Skin Fibrosis. Am J Respir Crit Care Med. 2017 11 15; 196(10):1298-1310.
-
Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y, Brown CE, Calligaro G, Cassidy N, Corte TJ, Geissler K, Hassan AA, Johannson KA, Kairalla R, Kolb M, Kondoh Y, Quadrelli S, Swigris J, Udwadia Z, Wells A, Wijsenbeek M. Palliative care in interstitial lung disease: living well. Lancet Respir Med. 2017 12; 5(12):968-980.
-
Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Ross JC, San José Estépar R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM. The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes. Eur Respir J. 2017 Sep; 50(3).
-
Milger K, Yu Y, Brudy E, Irmler M, Skapenko A, Mayinger M, Lehmann M, Beckers J, Reichenberger F, Behr J, Eickelberg O, Königshoff M, Krauss-Etschmann S. Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development. Thorax. 2017 11; 72(11):1007-1020.
-
Iftikhar IH, Alghothani L, Sardi A, Berkowitz D, Musani AI. Transbronchial Lung Cryobiopsy and Video-assisted Thoracoscopic Lung Biopsy in the Diagnosis of Diffuse Parenchymal Lung Disease. A Meta-analysis of Diagnostic Test Accuracy. Ann Am Thorac Soc. 2017 Jul; 14(7):1197-1211.
-
Distler O, Brown KK, Distler JHW, Assassi S, Maher TM, Cottin V, Varga J, Coeck C, Gahlemann M, Sauter W, Schmidt H, Highland KB. Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):75-81.
-
Ash SY, Harmouche R, Putman RK, Ross JC, Diaz AA, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Rosas IO, San Jose Estepar R, Washko GR. Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. Chest. 2017 10; 152(4):780-791.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|